Hari Group

We are a consulting firm offering strategic services to pharmaceutical and biotechnology companies. We are small, focused and experts in what we do. Our services are designed to help with Market Access, Business Development/ Licensing, Business Analysis, Strategic Planning, Strategic Marketing and Pricing & Reimbursement. We have the skills and resources to conduct market, product and service evaluations globally – USA, EU, Japan, China – including the emerging markets. We have extensive experience in conducting global opportunity assessments for medicines at all stages in their life cycle. We have been in this space for almost 15 years now and have conducted projects to support decisions around (a) funding for early stage companies, (b) advancing an asset across phases of clinical trials, (c) drug licensing opportunities, (d) valuation of revenue streams for monetization (e) pricing new products, (f) market scoping and (g) developing a viable target product profile. We have also developed forecasts for hundreds of new products, including valuations for many. We also develop health economic evaluations – patient level microsimulation models and Markov models – to support pricing and reimbursement. We have processes in place to provide results very rapidly to our clients with most projects taking under 4 weeks from commissioning to delivery. If you are a smaller consulting firm or a freelance consultant and require support with a consulting project, we can work with you at any stage of the project or for completing any module within the project. This may include help with secondary research, primary research globally, Excel model development for forecasting, Markov or decision tree model development for cost effectiveness analysis or just about any work associated with the project. Please feel free to email us (info@harico.in) with your requirement and telephone number.